The aim of this double-blind, parallel group study was to compare the effects of nebivolol
and atenolol on blood pressure (BP) and insulin sensitivity in hypertensive patients with type …

A double-blind, randomised, parallel-group trial was conducted in patients with essential
hypertension in British general practices, of nebivolol 5 mg, atenolol 50 mg, and placebo …

Beta‐blockers are well‐established therapeutic agents in the treatment of hypertension and
cardiovascular disease. However, these agents are highly heterogeneous. Beta‐blockers …

Objective: The aim of the present study is to compare the antihypertensive effects of
carvedilol and nebivolol in mild to moderate hypertensive patients. Methods: It is a …

Objective: The pharmacokinetics of a single iv dose of the new racemic β-adrenoceptor-
blocker nebivolol [0.073 mg base· kg–1 ideal body weight (IBW)] was studied in 9 obese …

Nebivolol is a new cardioselective beta-blocking agent possessing vasodilatory properties
involving the endothelium. This compound is a dl-racemic mixture. The d-enantiomer is …

Purpose We evaluated the efficacy and safety of nebivolol and rosuvastatin combination
treatment in patients with hypertension and hyperlipidemia. Patients and Methods Eligible …

Acute, subacute, and chronic treatment with nebivolol, a novel β1-selective adrenergic
antagonist, significantly lowered systolic and diastolic blood pressure and heart rate in …

Background The fixed-dose combination of any two antihypertensive drugs from different
drug classes is typically more effective in reducing blood pressure than a dose increase of …

Objectives: To study the effect of nebivolol 5 mg once daily versus (S)-atenolol 25 mg once
daily in patients with essential hypertension. Materials and Methods: A prospective study …